KYMRIAH

DRUG2 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Novartis Pharmaceuticals

Conditions

Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia (ALL)Diffuse Large B-Cell Lymphoma (DLBCL)Large B-cell Lymphoma

Phase 2

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Active, not recruitingNCT03642626

Masonic Cancer Center, University of MinnesotaAcute Lymphoblastic Leukemia, Large B-cell Lymphoma

Start: 2018-12-18End: 2028-06-01Updated: 2026-01-23

Unknown Phase

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

CompletedNCT05349201

Novartis PharmaceuticalsAcute Lymphoblastic Leukemia (ALL), Diffuse Large B-Cell Lymphoma (DLBCL)

Start: 2020-12-09End: 2021-05-28Updated: 2022-07-01